Predicted 10-year cardiovascular disease risk

Biomarker

1 paper2 findings

  • Human trial1

Interventions

1

Mhenal

downin humans1

1 study
  1. Mhenal decreases predicted 10-year cardiovascular disease risk in humans (Reported risk-category proportion: 10.0% to 6.2%; control: 11.0% to 9.7%).

    “The intervention significantly reduced the proportion of participants with a 10-year CVD risk from 10.0% to 6.2% (p=0.003)”

    Human trialOverweight and obese adults in urban Sri LankaAutomated text and voice messages in participants' native languageTwo text messages and two voice messages per week12 monthsn = 600

    Messages may lower predicted heart and blood vessel disease risk

    medRxiv12 Oct 2026Preprint

More on Mhenal

Associations

1

NfL

upin humans1

1 study
  1. Predicted 10-year cardiovascular disease risk is associated with NfL in humans (r=0.23, p <0.001).

    “and 10‐year cardiovascular risk (r=0.23, p <0.001).”

    Humansn = 237

    Association of cardiovascular disease risk and blood biomarkers of Alzheimer's disease

    AAIC 2025 abstract25 Dec 2025

More on NfL

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 12 in 12 months
medRxiv

Messages may lower predicted heart and blood vessel disease risk

The reported share at predicted risk of heart and blood vessel disease fell from 10.0% to 6.2% with messages, versus 11.0% to 9.7% with usual care.The reported share at predicted risk of heart and blood vessel disease fell from 10.0% to 6.2% with messages, versus 11.0% to 9.7% with usual care.

Preprint: randomised trial in 1,200 peopleInterventions